Bioinformatic Analysis of Genes and MicroRNAs Associated With Atrioventricular Septal Defect in Down Syndrome Patients.

Down syndrome (DS) is a common chromosome 21 abnormality disease, leading to various health problems, especially atrioventricular septal defect (AVSD). Genes and microRNAs (miRNAs) associated with AVSD in DS patients still need in-depth study.Gene expression data (GSE34457) of 22 DS patients without congenital heart disease and 7 DS patients with AVSD were downloaded from Gene Expression Omnibus. After screening differentially expressed genes (DEGs) based on limma package in R (criteria: P < 0.05 and |log2 fold change (FC)| > 0.5), pathway and functional enrichment analyses were performed using the online software DAVID (criterion: P < 0.05). The protein-protein interaction (PPI) networks of DEGs were constructed based on the online server STRING (criterion: combined score > 0.4). Next, miRNAs that targeted DEGs were predicted based on Webgestalt (criteria: P < 0.05 and target DEGs ≥ 2), and miRNA-DEG regulatory networks were visualized through Cytoscape.A total of 179 DEGs were identified. Next, 5 functions and 1 pathway were enriched by up-regulated DEGs, while 4 functions were enriched by down-regulated DEGs. Furthermore, miRNA-DEG regulatory networks were constructed. IL1B was the hub-gene of PPI networks, and AUTS2 and KIAA2022 were predicted to be targeted by miR-518a, miR518e, miR-518f, miR-528a, and miR-96.IL1B, IL12RB2, AUTS2, and KIAA2022 might participate in AVSD in DS patients, and AUTS2 and KIAA2022 might be targeted by miR-518a, miR-518e, miR-518f, miR-528a, and miR-96. The identified genes and miRNAs might provide a theoretical basis for understanding AVSD in DS patients.

[1]  M. Yamaoka-Tojo,et al.  Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-κB Pathway. , 2015, International heart journal.

[2]  Takeshi Kimura,et al.  MicroRNAs and High-Density Lipoprotein Cholesterol Metabolism. , 2015, International heart journal.

[3]  P. Su,et al.  microRNA-340-5p Functions Downstream of Cardiotrophin-1 to Regulate Cardiac Eccentric Hypertrophy and Heart Failure via Target Gene Dystrophin. , 2015, International heart journal.

[4]  Da-Zhi Wang,et al.  Loss of MicroRNA-155 Protects the Heart From Pathological Cardiac Hypertrophy , 2014, Circulation research.

[5]  S. Dey,et al.  COL6A1 loss of function mutation underlie atrioventricular septal defects in down syndrome patients , 2014, Molecular Cytogenetics.

[6]  Xian-Xian Zhao,et al.  Comparison of medium-term results of transcatheter correction versus surgical treatment for secundum type atrial septal defect combined with pulmonary valve stenosis. , 2014, International heart journal.

[7]  M. Tohyama,et al.  XLMR protein related to neurite extension (Xpn/KIAA2022) regulates cell–cell and cell–matrix adhesion and migration , 2013, Neurochemistry International.

[8]  N. Ahituv,et al.  The role of AUTS2 in neurodevelopment and human evolution. , 2013, Trends in genetics : TIG.

[9]  S. Haas,et al.  Loss of function of KIAA2022 causes mild to severe intellectual disability with an autism spectrum disorder and impairs neurite outgrowth. , 2013, Human molecular genetics.

[10]  Jing Wang,et al.  WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 , 2013, Nucleic Acids Res..

[11]  Jian-peng Teoh,et al.  MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Cardiac Disease , 2013 .

[12]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[13]  Xiao-Ming Gao,et al.  The Therapeutic Potential of microRNA-652 for the Treatment of Heart Failure , 2013 .

[14]  T. Yamaoka,et al.  MicroRNA 210 as a biomarker for congestive heart failure. , 2013, Biological & pharmaceutical bulletin.

[15]  Gary D Bader,et al.  A travel guide to Cytoscape plugins , 2012, Nature Methods.

[16]  Lora J. H. Bean,et al.  An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. , 2012, American journal of human genetics.

[17]  Hui Zhang,et al.  miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer. , 2012, Oncology letters.

[18]  A. Mégarbané,et al.  Molecular Signatures of Cardiac Defects in Down Syndrome Lymphoblastoid Cell Lines Suggest Altered Ciliome and Hedgehog Pathways , 2012, PloS one.

[19]  M. Knight,et al.  Primary cilia elongation in response to interleukin-1 mediates the inflammatory response , 2012, Cellular and Molecular Life Sciences.

[20]  G. Ailhaud,et al.  Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. , 2012, The Journal of clinical investigation.

[21]  F. Hickey,et al.  Medical update for children with Down syndrome for the pediatrician and family practitioner. , 2012, Advances in pediatrics.

[22]  E. Olson,et al.  JAK/Stat signaling regulates heart precursor diversification in Drosophila , 2011, Development.

[23]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[24]  David Patterson,et al.  Molecular genetic analysis of Down syndrome , 2009, Human Genetics.

[25]  Sanjiv S. Gambhir,et al.  Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes , 2008, PloS one.

[26]  Anthony J. Muslin,et al.  MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. , 2008, Clinical science.

[27]  K. Yutzey,et al.  Regulation of Cardiomyocyte Proliferation and Myocardial Growth During Development by FOXO Transcription Factors , 2008, Circulation research.

[28]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[29]  J M Delabar,et al.  Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. , 2007, American journal of human genetics.

[30]  Lora J. H. Bean,et al.  CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome , 2006, American journal of medical genetics. Part A.

[31]  K. Linask,et al.  Cross Talk between Cell–Cell and Cell–Matrix Adhesion Signaling Pathways during Heart Organogenesis: Implications for Cardiac Birth Defects , 2005, Microscopy and Microanalysis.

[32]  M. Yacoub,et al.  Complete atrioventricular septal defect, Down syndrome, and surgical outcome: risk factors. , 2003, The Annals of thoracic surgery.

[33]  N. Maulik,et al.  JAK/STAT Signaling Is Associated With Cardiac Dysfunction During Ischemia and Reperfusion , 2001, Circulation.

[34]  E. Hook.  The consequences of chromosome imbalance: Principles, mechanisms, and models , 1987 .

[35]  C. Epstein.  The Consequences of Chromosome Imbalance: The Consequences of Chromosome Imbalance , 1986 .